Cart
sales@molnova.com
IDO-IN-12
CAS No. 1888341-29-4
IDO-IN-12( —— )
Catalog No. M26255 CAS No. 1888341-29-4
IDO-IN-12 is an inhibitor of indoleamine 2,3-dioxygenase (IDO).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 188 | In Stock |
|
| 5MG | 180 | In Stock |
|
| 10MG | 264 | In Stock |
|
| 25MG | 416 | In Stock |
|
| 50MG | 529 | In Stock |
|
| 100MG | 737 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIDO-IN-12
-
NoteResearch use only, not for human use.
-
Brief DescriptionIDO-IN-12 is an inhibitor of indoleamine 2,3-dioxygenase (IDO).
-
DescriptionIDO-IN-12 is an inhibitor of indoleamine 2,3-dioxygenase (IDO).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetIDO
-
RecptorGPR52
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1888341-29-4
-
Formula Weight416.23
-
Molecular FormulaC13H11BrFN5O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (240.25 mM)
-
SMILESCSCCNc1nonc1-c1noc(=O)n1-c1ccc(F)c(Br)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tokumaru K, et al. Design, synthesis, and pharmacological evaluation of 4-azolyl-benzamide derivatives as novel GPR52 agonists. Bioorg Med Chem. 2017 Jun 15;25(12):3098-3115.
molnova catalog
related products
-
Chelidonine
Chelidonine isolated from Chelidonium majus efficiently induced apoptosis in HeLa cells through possible alteration of p38-p53 and AKT/PI3 kinase signalling pathways.
-
TAS-301
TAS-301, an inhibitor of smooth muscle cell migration and proliferation, inhibits intimal thickening after balloon injury to rat carotid arteries.
-
Navoximod
Navoximod (NLG-?919, GDC-0919) is a potent indoleamine-(2,3)-dioxygenase (IDO) pathway inhibitor (Ki/EC50: 7 nM/75 nM).
